Work

Psoriatic Arthritis Linked to Pembrolizumab in a Lung Cancer Patient: From Oncologist to Rheumatologist

Year: 2025

Type: article

Abstract: Immune-related rheumatic adverse effects (rheumatic IAEs) are commonly observed in patients undergoing immunotherapy for solid tumors and hematologic malignancies. The Romanian National Health Insurance House offers all patients free access to oncology medications and has significantly improved in recent years. Here, we present a case of a 69-year-old male patient diagnosed with a bronchopulmonary neoplasm who developed psoriatic arthritis (PsA) after receiving immunotherapy with pembrolizumab, emphasizing the challenges of therapeutic management in this case.

Source: Cureus

DOI: 10.7759/cureus.92171

Authors: Mihaela-Maria Pasca Fenesan, Elena Sirbu, Andreea Iana

Institutions: Victor Babeș University of Medicine and Pharmacy Timișoara, West University of Timişoara

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: diamond

OpenAlex ID: W4414269304

FWCI:

Cites: 19

Cited by:

Related to: